Department of Demography and Geodemography, Faculty of Science, Charles University, Prague 12800, Czech Republic.
J Public Health (Oxf). 2024 Feb 23;46(1):97-106. doi: 10.1093/pubmed/fdad278.
The COVID-19 pandemic may have caused an underestimation of cardiovascular disease (CVD) mortality, as COVID-19 was predominantly recorded as the underlying cause of death. This study investigates CVD-related excess mortality and recording of CVD on the death certificates during 2020-2021, considering underlying (underlying causes of death (UCD)), immediate and contributory causes.
We utilize US Multiple-Cause-of-Death Mortality Data. Excess deaths are assessed by comparing actual 2020-2021 deaths with Seasonal Autoregressive Integrated Moving Average model predictions. To understand changes in cause-of-death recording, we use the standardized ratio of multiple to underlying causes (SRMU).
Excess CVD mortality is most prominent in contributory causes, including hypertensive disease, essential hypertension, and acute myocardial infarction. While excess of contributory CVDs generally decreased in 2021, acute myocardial infarction, pulmonary heart diseases and other circulatory diseases showed a continual increase. Changes in SRMU from 2020 to 2021, compared to 2010-2019, reveal shifts in coding practices, particularly for pulmonary heart, cerebrovascular diseases, non-rheumatic valve disorders and heart failure.
The COVID-19 pandemic has significantly increased CVD-related mortality, which is not fully captured in conventional analyses based solely on the UCD. The trend of coding CVDs as non-underlying causes of death accelerated during 2020-2021. Multiple-causes-of-death should be employed to evaluate mortality when new leading cause of death emerges.
COVID-19 大流行可能导致心血管疾病(CVD)死亡率被低估,因为 COVID-19 主要被记录为死亡的根本原因。本研究调查了 2020-2021 年期间与 CVD 相关的超额死亡率和 CVD 在死亡证明上的记录情况,同时考虑了根本原因(根本死因(UCD))、直接原因和促成原因。
我们利用美国多原因死亡率数据。通过将实际的 2020-2021 年死亡人数与季节性自回归综合移动平均模型预测进行比较来评估超额死亡人数。为了了解死因记录变化,我们使用多种原因与根本原因的标准化比例(SRMU)。
在促成原因中,CVD 死亡率的超额情况最为明显,包括高血压病、原发性高血压和急性心肌梗死。虽然 2021 年促成 CVD 超额的情况总体呈下降趋势,但急性心肌梗死、肺心病和其他循环系统疾病仍持续增加。与 2010-2019 年相比,2020-2021 年 SRMU 的变化反映了编码实践的转变,特别是在肺心病、脑血管病、非风湿性瓣膜疾病和心力衰竭方面。
COVID-19 大流行显著增加了与 CVD 相关的死亡率,而仅基于 UCD 的传统分析并未充分捕捉到这一点。2020-2021 年期间,将 CVD 编码为非根本死因的趋势加速。当出现新的主要死因时,应采用多死因分析来评估死亡率。